论文部分内容阅读
至今胰腺癌仍然是严重致命的疾病。99％以上的胰腺癌患者最终死于这种病。手术切除是唯一可能治愈的手段。切除率到处都很低仅5％～10％,肿瘤切除后平均生存时间仅17～20个月。化疗、放疗等辅助治疗几乎没有效果。治疗的结果令人丧气,但作者认为通过对病人进行精确分析和区别对待,有可能改进胰腺癌病人尚存生命居者的生活质量,并尽可能地延长生存时间。本文运用对胰腺诊断、术前分期及治疗的最新资料,将病人分成:1.可切除的;2.局限但不能切除的;3.已有转移的胰腺导管腺癌三个组来进行讨论。
Pancreatic cancer is still a serious and deadly disease. More than 99% of pancreatic cancer patients eventually died of this disease. Surgical removal is the only possible cure. The resection rate is very low at only 5% to 10%. The average survival time after tumor resection is only 17 to 20 months. Adjuvant treatment such as chemotherapy and radiotherapy has almost no effect. The results of the treatment are frustrating, but the authors believe that by accurately analyzing and discriminating patients, it is possible to improve the quality of life of surviving survivors of pancreatic cancer and to extend survival as much as possible. This article uses the latest information on pancreatic diagnosis, preoperative staging and treatment, and divides patients into: 1. Resectable; 2. Localized but unresectable; 3. Three groups of pancreatic ductal adenocarcinomas that have been transferred for discussion.